PlainPharmaWatch

CMS Open Payments · Program Year 2024

Republic Spine

Republic Spine reported $567,334.68 across General Payments, Research, and Ownership to 45 physicians and teaching hospitals across 45 transactions.

See the rankings → How this is sourced
$567.3K Above-median payer
All-tracks total
45 Below-median volume
Transactions
45 Below-median reach
Recipients
−$64.5K
General Payments vs PY2023

Republic Spine reported $567,334.68 across all CMS Open Payments tracks (General + Research + Ownership) to 45 physicians and teaching hospitals in Program Year 2024 - ranking #734 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $567,334.68, averaging $12.6K per recipient.

Republic Spine's payment reach score

Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.

Overall reach score

F

15/100

Total payments

F

15/100

Transaction volume

F

10/100

Physician reach

F

10/100

Payment type diversity

F

23/100

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer republic-spine Republic Spine

$567.3K · #734/1,925 · 0.0% industry · PY2024

  • TOT $567.3K
  • RANK #734
  • SHARE 0.0%
  • TXN 45
  • RCP 45
  • CAT 2
  • GEN $567.3K
  • ΔGEN −$64.5K
  • TOP1 45.8%
  • PY 2024

Volume peers

Nearest volume peer: Perfuze Limited ($568.2K)

Hyperfine Operations, Inc.$568.6KPerfuze Limited$568.2KRepublic Spine (this)$567.3KExpanding Innovations, Inc.$566.5KCTL Medical Corporation$565.3K
All-tracks payment totals near Republic Spine (CMS Open Payments PY2024)

Republic Spine sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

Republic Spine's CMS-reported General Payments decreased by $64.5K (−10.2%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: REPUBLIC SPINEPY2023: REPUBLIC SPINEPY2024: Republic Spine. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$631.8KPY2024$567.3K
PY2023
$631,834.53
PY2024
$567,334.68

What the Data Shows for Republic Spine

The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Republic Spine that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.

"Royalty or License" leads the 2-category general-payment breakdown below at $565.3K (99.6% of General Payments, 31 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

"Royalty or License" leads Republic Spine's 2-category general-payment breakdown at $565.3K, 99.6% of the reported total.

How Republic Spine divides its payments

General-payment categories, ordered by reported total

1. Royalty or License$565.3K2. Food and Beverage$2.1K
Payment Type Amount Transactions
Royalty or License $565.3K 31
Food and Beverage $2.1K 14

Recipient Concentration in General Payments

The five largest recipient relationships account for $566,455.26 (99.8%) of $567,334.68 in this company's General Payments records across 11 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Republic Spine

The five named recipients with the highest reported General Payments from this company

Timur Urakov$260.1KSimon Chao$119.2KLawrence Babat$96.0KLuis Duarte$90.8KRaphael Roybal$429.55
  1. 1

    Timur Urakov

    $260,100.00 across 11 reported transactions

  2. 2

    Simon Chao

    $119,175.71 across 9 reported transactions

  3. 3

    Lawrence Babat

    $96,000.00 across 5 reported transactions

  4. 4

    Luis Duarte

    $90,750.00 across 9 reported transactions

  5. 5

    Raphael Roybal

    $429.55 across 5 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Spend vs. Concentration

Republic Spine's spend rank (#734 of 1,925, top 38% by spend) and concentration rank (#556 of 1,838, top 30% most concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.

02.14.26.38.43046.33077.43108.53139.63170.7Total payments ($M)Concentration (HHI, 0-10,000)
Republic Spine (highlighted) among its 12 nearest HHI-concentration neighbors, Program Year 2024. Dashed lines mark this neighborhood's median payment total and median HHI. Hover a point for the company name. Source: company_concentration (CMS Open Payments general-payment recipients).
View all 12 companies in this HHI neighborhood as a list

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Republic Spine's, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Republic Spine.

Lumenis BE LTD

HHI 3093

Cook Research Incorporated

HHI 3073

Delphinus Medical Technologies, Inc.

HHI 3070

Asklepios Biopharmaceutical Inc.

HHI 3111

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Republic Spine.

Showing 6 of 1,924 companies with CMS-reported payment data.

Put this to use

Republic Spine ranks #734 of 1,925 by all-tracks total payments, led by "Royalty or License".

Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Republic Spine's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.